LAVA Therapeutics Announces Two Appointments to its Board of Directors
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Stay updated with breaking news from Acceleron Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
/PRNewswire/ -- The global active pharmaceutical ingredients market size is expected to reach USD 353.0 billion by 2030, expanding at a compound annual growth...
Anemia Therapeutics Market Top Companies Analysis 2022 | North America, Europe, South America and Middle East & Africa | 2022-06-06 12:54:31
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced that the company has withdrawn a supplemental biologics license application (sBLA) for Reblozyl® (luspatercept-aamt) for the treatment of anemia in adults with non-transfusion dependent (NTD) beta thalassemia. The Company could not ap...
Randolph, MA (PRWEB) May 23, 2022 -- The FSHD Society, a research-focused patient advocacy nonprofit dedicated to bringing treatments to patients affected by